MedTrace Logo

Early rhBNP on Myocardial Work in Patients With STEMI

NCT04157868 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2019-11-08

No results posted yet for this study

Summary

The study intends to evaluate the efficacy of early rhBNP on myocardial work in patients with anterior ST-segment elevation myocardial infarction after percutaneous coronary intervention

Conditions

  • ST-Segment Elevated Myocardial Infarction

Interventions

DRUG

rhBNP

rhBNP intra-coronary injection 1.5 ug/kg loading dose, with intravenous injection 0.0075-0.01 ug/kg/min persistent for 72 hour.

DRUG

Control

Saline intra-coronary injection 0.15ml/kg loading dose, with same intravenous injection speed for 72 hour.

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Song Ding, MD,Ph.D. · Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-30
Primary Completion
2022-09-30
Completion
2022-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04157868 on ClinicalTrials.gov